Jalandhar Online

Head and Neck Squamous Cell Carcinoma Epidemiology Forecast Report 2030 | Head and Neck Squamous Cell Carcinoma Epidemiology Analysis 2030 | DelveInsight

 Breaking News
  • No posts were found

Head and Neck Squamous Cell Carcinoma Epidemiology Forecast Report 2030 | Head and Neck Squamous Cell Carcinoma Epidemiology Analysis 2030 | DelveInsight

October 13
02:56 2021
Head and Neck Squamous Cell Carcinoma Epidemiology Forecast Report 2030 | Head and Neck Squamous Cell Carcinoma Epidemiology Analysis 2030 | DelveInsight
DelveInsight Business Research LLP
DelveInsight’s “Head and Neck Squamous Cell Carcinoma – Epidemiology Forecast to 2030” report delivers an in-depth understanding of the disease, historical and forecasted Head and Neck Squamous Cell Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight launched a new report on Head and Neck Squamous Cell Carcinoma Epidemiology Forecast, 2030.

DelveInsight’s ‘Head and Neck Squamous Cell Carcinoma Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Head and Neck Squamous Cell Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Head and neck cancer is a term used to define cancer that develops in the mouth (oral cavity), throat, nose, salivary glands, oral cancers, or other areas of the head and neck. Most of these are classified as squamous cases which cover 90% of the disease area. The causes of head and neck cancers are not fully understood. There are certain risk factors that increase the risk of developing the disease such as smoking tobacco, consumption of alcohol, and exposure to the human papillomavirus (HPV) which contributes to the development of at least 90% of squamous cell carcinoma of the head and neck. At least 12% of pharyngeal cancer, 3% of oral cancer, and 30–60% of oropharyngeal carcinoma cases are caused by HPV infection.

Some of the key highlights from the Head and Neck Squamous Cell Carcinoma Epidemiology Report:

  1. According to an Organization, 2014, The annual incidence of head and neck cancers worldwide is more than 550,000 cases with around 300,000 deaths each year. The male to female ratio ranges from 2:1 to 4:1. About 90% of all head and neck cancers are squamous cell carcinomas. 

  2. SCC is the most frequent malignant tumor of the head and neck region. HNSCC represents the sixth leading cancer by incidence and there are 500,000 new cases a year worldwide (Kamangar et al., 2006). 

Visit for more @ Head and Neck Squamous Cell Carcinoma Epidemiology Insights

Scope of the Head and Neck Squamous Cell Carcinoma Epidemiology report:

  1. The Head and Neck Squamous Cell Carcinoma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns

  2. The Head and Neck Squamous Cell Carcinoma Epidemiology Report and Model provide an overview of the risk factors and global trends of Head and Neck Squamous Cell Carcinoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

  3. The report provides insight into the historical and forecasted patient pool of Head and Neck Squamous Cell Carcinoma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

  4. The report helps to recognize the growth opportunities in the 7MM concerning the patient population

  5. The report assesses the disease risk and burden and highlights the unmet needs of Head and Neck Squamous Cell Carcinoma

  6. The report provides the segmentation of the Head and Neck Squamous Cell Carcinoma epidemiology

Table of Contents:

1. Key Insights

2. Executive Summary of Head and Neck Squamous Cell Carcinoma

3. Head and Neck Squamous Cell Carcinoma Epidemiology Overview at a Glance

4. Head and Neck Squamous Cell Carcinoma: Disease Background and Overview

5. Epidemiology and Patient Population

6. Case Reports

7. Country Wise-Epidemiology of Head and Neck Squamous Cell Carcinoma 

8. Appendix

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Read more on Head and Neck Squamous Cell Carcinoma Epidemiological Insights

Related Reports:

Head and Neck Squamous Cell Carcinoma Market

DelveInsight’s ‘Head and Neck Squamous Cell Carcinoma-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/